Last 12 months
Inside the activity.
0 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 10, 2018 Filed Dec 10, 2018 23:38 UTC |
Kuipers Peter J.Executive V P& CFO
|
Exercise / conversionCommon Stock | 5,574 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-013647 · edgar.xml · nonDerivative · entry 2 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,116 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| November 06, 2018 Filed Dec 6, 2018 16:00 UTC |
SPEARS JOSEPH BRIANChief Accounting Officer & VP
|
GrantStock Options NQ (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $69.70 | $0.00 |
DisclosureSEC source: 0001179110-18-013474 · edgar.xml · derivative · entry 4 SPEARS JOSEPH BRIAN · CIK 0001729964 · Chief Accounting Officer & VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2018-11-05 F3 · derivative.underlying_shares: Shares shall vest ratably over 48 month period, with a year cliff. Read SEC document |
| November 06, 2018 Filed Dec 6, 2018 16:00 UTC |
SPEARS JOSEPH BRIANChief Accounting Officer & VP
|
GrantCommon Stock | 2,150 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-013474 · edgar.xml · nonDerivative · entry 3 SPEARS JOSEPH BRIAN · CIK 0001729964 · Chief Accounting Officer & VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,684 F4 · shares: Restricted stock units shall vest quarterly from 12/15 and 3/15, 6/15 and 9/15. Read SEC document |
| November 02, 2018 Filed Nov 5, 2018 17:23 UTC |
Judson James TDirector
|
SaleCommon Stock | 5,949 | $69.29 | $412,193.12 |
DisclosureSEC source: 0001179110-18-012529 · edgar.xml · nonDerivative · entry 2 Judson James T · CIK 0001326789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,560 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F2 · price: The price reported in Column 4 is the average price of $69.2878. The shares sold between 69.00 and 69.75. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 01, 2018 Filed Nov 1, 2018 19:46 UTC |
Judson James TDirector
|
SaleCommon Stock | 2,443 | $70.67 | $172,646.81 |
DisclosureSEC source: 0001179110-18-012441 · edgar.xml · nonDerivative · entry 2 Judson James T · CIK 0001326789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,509 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F2 · price: The price reported in Column 4 is the average price of $70.67. The sold price was $70.67. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 15, 2018 Filed Oct 15, 2018 21:24 UTC |
JOHNSTON DAN SEVP & Chief Legal & Admin
|
Exercise / conversionStock Options NQ (right to Buy) · Derivative | 6,250 | $0.00 Strike: $34.02 | $0.00 |
DisclosureSEC source: 0001179110-18-012183 · edgar.xml · derivative · entry 4 JOHNSTON DAN S · CIK 0001271802 · EVP & Chief Legal & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,250 Underlying: Common Stock · 6,250 shares Expires 2025-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| October 15, 2018 Filed Oct 15, 2018 21:24 UTC |
JOHNSTON DAN SEVP & Chief Legal & Admin
|
SaleCommon Stock | 6,250 | $63.47 | $396,703.75 |
DisclosureSEC source: 0001179110-18-012183 · edgar.xml · nonDerivative · entry 3 JOHNSTON DAN S · CIK 0001271802 · EVP & Chief Legal & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,996 F1 · price: The price reported in Column 4 is the average price of $63.4726. The sold price range was between $62.62 to $64.10. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 15, 2018 Filed Oct 15, 2018 21:24 UTC |
JOHNSTON DAN SEVP & Chief Legal & Admin
|
Exercise / conversionCommon Stock | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-012183 · edgar.xml · nonDerivative · entry 2 JOHNSTON DAN S · CIK 0001271802 · EVP & Chief Legal & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,246 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| October 01, 2018 Filed Oct 1, 2018 21:57 UTC |
Judson James TDirector
|
SaleCommon Stock | 5,000 | $71.18 | $355,899.50 |
DisclosureSEC source: 0001179110-18-011784 · edgar.xml · nonDerivative · entry 2 Judson James T · CIK 0001326789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,952 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F2 · price: The price reported in Column 4 is the average price of $71.1799. The sold price range was $70.60 to $71.96. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 15, 2018 Filed Dec 6, 2018 16:00 UTC |
SPEARS JOSEPH BRIANChief Accounting Officer & VP
|
Tax withholdingCommon Stock | 175 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-013474 · edgar.xml · nonDerivative · entry 2 SPEARS JOSEPH BRIAN · CIK 0001729964 · Chief Accounting Officer & VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,534 F1 · price: The sales reported in this Form 4 were mainly to cover tax withholding obligations in connection with the vesting of restricted stock units that occurred immediately prior to the date of sale. Read SEC document |
| September 10, 2018 Filed Sep 10, 2018 22:59 UTC |
Kuipers Peter J.Executive V P& CFO
|
Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 1,884 | $0.00 Strike: $36.70 | $0.00 |
DisclosureSEC source: 0001179110-18-011261 · edgar.xml · derivative · entry 10 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,884 Underlying: Common Stock · 1,884 shares Expires 2027-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| September 10, 2018 Filed Sep 10, 2018 22:59 UTC |
Kuipers Peter J.Executive V P& CFO
|
Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 261 | $0.00 Strike: $36.70 | $0.00 |
DisclosureSEC source: 0001179110-18-011261 · edgar.xml · derivative · entry 9 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261 Underlying: Common Stock · 261 shares Expires 2027-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| September 10, 2018 Filed Sep 10, 2018 22:59 UTC |
Kuipers Peter J.Executive V P& CFO
|
Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 1,086 | $0.00 Strike: $27.70 | $0.00 |
DisclosureSEC source: 0001179110-18-011261 · edgar.xml · derivative · entry 8 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,086 Underlying: Common Stock · 1,086 shares Expires 2027-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| September 10, 2018 Filed Sep 10, 2018 22:59 UTC |
Kuipers Peter J.Executive V P& CFO
|
Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 2,343 | $0.00 Strike: $32.78 | $0.00 |
DisclosureSEC source: 0001179110-18-011261 · edgar.xml · derivative · entry 7 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,373 Underlying: Common Stock · 2,343 shares Expires 2025-09-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| September 10, 2018 Filed Sep 10, 2018 22:59 UTC |
Kuipers Peter J.Executive V P& CFO
|
SaleCommon Stock | 1,884 | $68.82 | $129,652.55 |
DisclosureSEC source: 0001179110-18-011261 · edgar.xml · nonDerivative · entry 6 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,542 F5 · price: The price reported in Column 4 is the average price of $68.8177. The sold price range was between $68.7250 to $69.15. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 10, 2018 Filed Sep 10, 2018 22:59 UTC |
Kuipers Peter J.Executive V P& CFO
|
SaleCommon Stock | 261 | $68.94 | $17,992.30 |
DisclosureSEC source: 0001179110-18-011261 · edgar.xml · nonDerivative · entry 5 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,426 F4 · price: The price reported in Column 4 is the average price of $68.9360. The sold price range was between $68.85 to $69.025. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 10, 2018 Filed Sep 10, 2018 22:59 UTC |
Kuipers Peter J.Executive V P& CFO
|
SaleCommon Stock | 1,086 | $68.78 | $74,698.99 |
DisclosureSEC source: 0001179110-18-011261 · edgar.xml · nonDerivative · entry 4 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,687 F3 · price: The price reported in Column 4 is the average price of $68.7836. The sold price range was between $68.725 to $69.95. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 10, 2018 Filed Sep 10, 2018 22:59 UTC |
Kuipers Peter J.Executive V P& CFO
|
SaleCommon Stock | 2,343 | $68.94 | $161,515.88 |
DisclosureSEC source: 0001179110-18-011261 · edgar.xml · nonDerivative · entry 3 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,773 F2 · price: The price reported in Column 4 is the average price of $68.9355. The shares sold between $68.7250 to $69.40. This transaction was effected to reflect additional shares that should have been sold on July 16, 2018 pursuant to the 10b5-1 trading plan that were not in fact sold because of an administrative broker error in executing the plan. Read SEC document |
| September 10, 2018 Filed Sep 10, 2018 22:59 UTC |
Kuipers Peter J.Executive V P& CFO
|
Exercise / conversionCommon Stock | 5,574 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-011261 · edgar.xml · nonDerivative · entry 2 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,116 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| September 04, 2018 Filed Sep 4, 2018 22:54 UTC |
Judson James TDirector
|
SaleCommon Stock | 5,000 | $68.90 | $344,524.00 |
DisclosureSEC source: 0001179110-18-011099 · edgar.xml · nonDerivative · entry 2 Judson James T · CIK 0001326789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,952 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F2 · price: The price reported in Column 4 is the average price of $68.9048. The sold price range was $68.60 to $69.33. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 14, 2018 Filed Aug 14, 2018 21:48 UTC |
Kuipers Peter J.Executive V P& CFO
|
SaleCommon Stock | 10 | $63.25 | $632.50 |
DisclosureSEC source: 0001179110-18-010586 · edgar.xml · nonDerivative · entry 2 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,542 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F2 · price: The price reported in Column 4 is the exact price of $63.25 at which all shares were sold. This transaction was effected to reflect additional shares that should have been sold on July 16, 2018 pursuant to the 10b5-1 trading plan that were not in fact sold because of an administrative broker error in executing the plan. Read SEC document |
| August 01, 2018 Filed Aug 2, 2018 17:06 UTC |
Taborga Jorge R.EVP, Global R & D
|
Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 7,859 | $0.00 Strike: $36.70 | $0.00 |
DisclosureSEC source: 0001179110-18-010118 · edgar.xml · derivative · entry 10 Taborga Jorge R. · CIK 0001571822 · EVP, Global R & D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,859 Underlying: Common Stock · 7,859 shares Expires 2027-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| August 01, 2018 Filed Aug 2, 2018 17:06 UTC |
Taborga Jorge R.EVP, Global R & D
|
Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 6,532 | $0.00 Strike: $27.70 | $0.00 |
DisclosureSEC source: 0001179110-18-010118 · edgar.xml · derivative · entry 9 Taborga Jorge R. · CIK 0001571822 · EVP, Global R & D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,532 Underlying: Common Stock · 6,532 shares Expires 2026-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| August 01, 2018 Filed Aug 2, 2018 17:06 UTC |
Taborga Jorge R.EVP, Global R & D
|
SaleCommon Stock | 888 | $58.71 | $52,136.97 |
DisclosureSEC source: 0001179110-18-010118 · edgar.xml · nonDerivative · entry 8 Taborga Jorge R. · CIK 0001571822 · EVP, Global R & D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,720 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F7 · price: The price reported in Column 4 is the average price of $58.7128. The sold price range was $58.15 to $59.70. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 01, 2018 Filed Aug 2, 2018 17:06 UTC |
Taborga Jorge R.EVP, Global R & D
|
SaleCommon Stock | 837 | $59.02 | $49,398.15 |
DisclosureSEC source: 0001179110-18-010118 · edgar.xml · nonDerivative · entry 7 Taborga Jorge R. · CIK 0001571822 · EVP, Global R & D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,608 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F6 · price: The price reported in Column 4 is the average price of $59.0181. The sold price range was $58.20 to $59.675. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 01, 2018 Filed Aug 2, 2018 17:06 UTC |
Taborga Jorge R.EVP, Global R & D
|
SaleCommon Stock | 738 | $58.70 | $43,320.01 |
DisclosureSEC source: 0001179110-18-010118 · edgar.xml · nonDerivative · entry 6 Taborga Jorge R. · CIK 0001571822 · EVP, Global R & D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,445 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F5 · price: The price reported in Column 4 is the average price of $58.6992. The sold price range was $58.15 to $59.675. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 01, 2018 Filed Aug 2, 2018 17:06 UTC |
Taborga Jorge R.EVP, Global R & D
|
SaleCommon Stock | 790 | $58.98 | $46,597.52 |
DisclosureSEC source: 0001179110-18-010118 · edgar.xml · nonDerivative · entry 5 Taborga Jorge R. · CIK 0001571822 · EVP, Global R & D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,183 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F4 · price: The price reported in Column 4 is the average price of $58.9842. The sold price range was $58.10 to $59.60. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 01, 2018 Filed Aug 2, 2018 17:06 UTC |
Taborga Jorge R.EVP, Global R & D
|
SaleCommon Stock | 7,859 | $58.76 | $461,776.76 |
DisclosureSEC source: 0001179110-18-010118 · edgar.xml · nonDerivative · entry 4 Taborga Jorge R. · CIK 0001571822 · EVP, Global R & D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,973 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F3 · price: The price reported in Column 4 is the average price of $58.7577. The sold price range was $58.05 to $59.60. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 01, 2018 Filed Aug 2, 2018 17:06 UTC |
Taborga Jorge R.EVP, Global R & D
|
SaleCommon Stock | 6,532 | $58.76 | $383,796.15 |
DisclosureSEC source: 0001179110-18-010118 · edgar.xml · nonDerivative · entry 3 Taborga Jorge R. · CIK 0001571822 · EVP, Global R & D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,832 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F2 · price: The price reported in Column 4 is the average price of $58.7563. The sold price range was $58.05 to $59.60. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 01, 2018 Filed Aug 2, 2018 17:06 UTC |
Taborga Jorge R.EVP, Global R & D
|
Exercise / conversionCommon Stock | 14,391 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-010118 · edgar.xml · nonDerivative · entry 2 Taborga Jorge R. · CIK 0001571822 · EVP, Global R & D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,364 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| August 01, 2018 Filed Aug 2, 2018 17:05 UTC |
Judson James TDirector
|
SaleCommon Stock | 5,000 | $58.76 | $293,812.00 |
DisclosureSEC source: 0001179110-18-010117 · edgar.xml · nonDerivative · entry 2 Judson James T · CIK 0001326789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,952 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F2 · price: The price reported in Column 4 is the average price of $58.7624. The sold price range was $58.05 to $59.70. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 16, 2018 Filed Jul 17, 2018 17:41 UTC |
Kuipers Peter J.Executive V P& CFO
|
SaleCommon Stock | 2,818 | $53.06 | $149,529.00 |
DisclosureSEC source: 0001179110-18-009729 · edgar.xml · nonDerivative · entry 2 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,552 F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F1 · price: The price reported in Column 4 is the average price of $53.0621. The sold price range was between $52.75 to $53.75. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 16, 2018 Filed Jul 17, 2018 17:41 UTC |
JOHNSTON DAN SEVP & Chief Legal & Admin
|
Exercise / conversionStock Options NQ (right to Buy) · Derivative | 2,500 | $0.00 Strike: $34.02 | $0.00 |
DisclosureSEC source: 0001179110-18-009728 · edgar.xml · derivative · entry 8 JOHNSTON DAN S · CIK 0001271802 · EVP & Chief Legal & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires 2025-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| July 16, 2018 Filed Jul 17, 2018 17:41 UTC |
JOHNSTON DAN SEVP & Chief Legal & Admin
|
Exercise / conversionStock Options NQ (right to Buy) · Derivative | 3,750 | $0.00 Strike: $25.08 | $0.00 |
DisclosureSEC source: 0001179110-18-009728 · edgar.xml · derivative · entry 7 JOHNSTON DAN S · CIK 0001271802 · EVP & Chief Legal & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,750 Underlying: Common Stock · 3,750 shares Expires 2024-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| July 16, 2018 Filed Jul 17, 2018 17:41 UTC |
JOHNSTON DAN SEVP & Chief Legal & Admin
|
SaleCommon Stock | 3,463 | $53.06 | $183,747.13 |
DisclosureSEC source: 0001179110-18-009728 · edgar.xml · nonDerivative · entry 6 JOHNSTON DAN S · CIK 0001271802 · EVP & Chief Legal & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,996 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F4 · price: The price reported in Column 4 is the average price of $53.0601. The sold price range was between $52.75 to $53.45. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote Read SEC document |
| July 16, 2018 Filed Jul 17, 2018 17:41 UTC |
JOHNSTON DAN SEVP & Chief Legal & Admin
|
SaleCommon Stock | 2,500 | $53.06 | $132,656.75 |
DisclosureSEC source: 0001179110-18-009728 · edgar.xml · nonDerivative · entry 5 JOHNSTON DAN S · CIK 0001271802 · EVP & Chief Legal & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,459 F2 · price: The price reported in Column 4 is the average price of $53.0627. The sold price range was between $52.95 to $53.75. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote Read SEC document |
| July 16, 2018 Filed Jul 17, 2018 17:41 UTC |
JOHNSTON DAN SEVP & Chief Legal & Admin
|
Exercise / conversionCommon Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-009728 · edgar.xml · nonDerivative · entry 4 JOHNSTON DAN S · CIK 0001271802 · EVP & Chief Legal & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,959 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| July 16, 2018 Filed Jul 17, 2018 17:41 UTC |
JOHNSTON DAN SEVP & Chief Legal & Admin
|
SaleCommon Stock | 3,750 | $53.05 | $198,925.13 |
DisclosureSEC source: 0001179110-18-009728 · edgar.xml · nonDerivative · entry 3 JOHNSTON DAN S · CIK 0001271802 · EVP & Chief Legal & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,459 F1 · price: The price reported in Column 4 is the average price of $53.0467. The sold price range was between $52.75 to $53.40. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 16, 2018 Filed Jul 17, 2018 17:41 UTC |
JOHNSTON DAN SEVP & Chief Legal & Admin
|
Exercise / conversionCommon Stock | 3,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-009728 · edgar.xml · nonDerivative · entry 2 JOHNSTON DAN S · CIK 0001271802 · EVP & Chief Legal & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,209 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| July 16, 2018 Filed Jul 17, 2018 17:40 UTC |
Taborga Jorge R.EVP, Global R & D
|
Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 1,563 | $0.00 Strike: $34.02 | $0.00 |
DisclosureSEC source: 0001179110-18-009727 · edgar.xml · derivative · entry 7 Taborga Jorge R. · CIK 0001571822 · EVP, Global R & D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,563 Underlying: Common Stock · 1,563 shares Expires 2025-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| July 16, 2018 Filed Jul 17, 2018 17:40 UTC |
Taborga Jorge R.EVP, Global R & D
|
Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 1,641 | $0.00 Strike: $25.08 | $0.00 |
DisclosureSEC source: 0001179110-18-009727 · edgar.xml · derivative · entry 6 Taborga Jorge R. · CIK 0001571822 · EVP, Global R & D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,641 Underlying: Common Stock · 1,641 shares Expires 2024-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| July 16, 2018 Filed Jul 17, 2018 17:40 UTC |
Taborga Jorge R.EVP, Global R & D
|
Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 1,421 | $0.00 Strike: $13.67 | $0.00 |
DisclosureSEC source: 0001179110-18-009727 · edgar.xml · derivative · entry 5 Taborga Jorge R. · CIK 0001571822 · EVP, Global R & D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,421 Underlying: Common Stock · 1,421 shares Expires 2022-10-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| July 16, 2018 Filed Jul 17, 2018 17:40 UTC |
Taborga Jorge R.EVP, Global R & D
|
SaleCommon Stock | 6,957 | $52.98 | $368,602.73 |
DisclosureSEC source: 0001179110-18-009727 · edgar.xml · nonDerivative · entry 4 Taborga Jorge R. · CIK 0001571822 · EVP, Global R & D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,973 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F3 · price: The price reported in Column 4 is the average price of $52.9830. The sold price range was between $52.70 to $53.75. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 16, 2018 Filed Jul 17, 2018 17:40 UTC |
Taborga Jorge R.EVP, Global R & D
|
SaleCommon Stock | 4,625 | $52.99 | $245,095.40 |
DisclosureSEC source: 0001179110-18-009727 · edgar.xml · nonDerivative · entry 3 Taborga Jorge R. · CIK 0001571822 · EVP, Global R & D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,930 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F2 · price: The price reported in Column 4 is the average price of $52.9936. The sold price range was between $52.70 to $53.75. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 16, 2018 Filed Jul 17, 2018 17:40 UTC |
Taborga Jorge R.EVP, Global R & D
|
Exercise / conversionCommon Stock | 4,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-009727 · edgar.xml · nonDerivative · entry 2 Taborga Jorge R. · CIK 0001571822 · EVP, Global R & D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,555 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| July 05, 2018 Filed Jul 5, 2018 22:52 UTC |
Ngo Nhat HEVP, Marketing, S & B D
|
SaleCommon Stock | 20,436 | $55.00 | $1,123,980.00 |
DisclosureSEC source: 0001179110-18-009504 · edgar.xml · nonDerivative · entry 2 Ngo Nhat H · CIK 0001305020 · EVP, Marketing, S & B D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,314 F1 · price: The price reported in Column 4 is the exact price of $55.00. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 19, 2018 Filed Jun 20, 2018 22:25 UTC |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
Exercise / conversionStock Options NQ (right to Buy) · Derivative | 18,154 | $0.00 Strike: $25.08 | $0.00 |
DisclosureSEC source: 0001179110-18-008859 · edgar.xml · derivative · entry 7 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,154 Underlying: Common Stock · 18,154 shares Expires 2025-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| June 19, 2018 Filed Jun 20, 2018 22:25 UTC |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
SaleCommon Stock | 18,154 | $52.00 | $944,008.00 |
DisclosureSEC source: 0001179110-18-008859 · edgar.xml · nonDerivative · entry 6 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191,265 F3 · price: The price reported in Column 4 is the exact price of $52.00 the shares sold. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 19, 2018 Filed Jun 20, 2018 22:25 UTC |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
Exercise / conversionCommon Stock | 18,154 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-008859 · edgar.xml · nonDerivative · entry 5 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,419 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| June 19, 2018 Filed Jun 20, 2018 22:25 UTC |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
SaleCommon Stock | 9,483 | $52.04 | $493,502.91 |
DisclosureSEC source: 0001179110-18-008859 · edgar.xml · nonDerivative · entry 4 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191,265 F5 · price: The price reported in Column 4 is the Average price of $52.0408. The shares sold between $51.35 to $52.25. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.